Written by: Jonathan Alsop, PhD | Posted on: 10-28-2020 | Category: RWD/RWEMy closer look at…. “What the Rise of Real-World Evidence Means for the Pharmaceutical Industry: A Closer Look”ISPOR’s Value and Outcomes Spotlight recent Sep/Oct 2020 issue contained an interesting Q&A article with Jennifer Graff (VP, Comparative-Effectiveness Research, National Pharmaceutical Council). Overall, it was interesting, ...Read More